No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
65192 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
987 |
6. Filter based on genotype QC (FinnGen only) |
987 |
Control definitions (FinnGen only)
- Control conditions
- not I9_AF
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Embolic stroke with flimmer
based on the number of shared cases.
Similar with more cases:
- Embolic stroke
- Ischaemic Stroke, excluding all haemorrhages
- Stroke, excluding SAH
- Stroke, including SAH
- Cerebrovascular diseases (FINNGEN)
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 16896 | 8436 | 8086 |
| Only index persons | 7367 | 3543 | 3824 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.24 | 0.24 | 0.23 |
| Only index persons | 0.14 | 0.13 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 74.92 | 77.54 | 72.31 |
| Only index persons | 74.78 | 78.33 | 71.50 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 987 | 331 | 656 |
| Unadjusted period prevalence (%) | 0.23 | 0.11 | 0.29 |
| Median age at first event (years) | 72.31 | 74.12 | 71.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 878
- Matched controls
- 8786
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
611.7
323.0
360
10
I48
ICD-10 Finland
Atrial fibrillation and flutter
911.9
323.0
790
86
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
323.0
317
*
B01AA03
ATC
warfarin; systemic
24.3
323.0
626
810
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
1095.3
323.0
739
42
207
Kela drug reimbursment
Chronic arrhythmias
160.3
323.0
442
55
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
12.9
232.4
502
819
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
14.3
217.3
421
530
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
53.2
187.7
224
56
C01AA05
ATC
digoxin; systemic
16.1
185.0
325
309
K78
ICPC
Atrial fibrillation/flutter
33.9
161.1
213
82
B01AF02
ATC
apixaban; oral
28.2
153.7
214
99
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
+∞
133.8
125
*
TFP20
NOMESCO Finland
Cardiodefibrillation
84.4
133.5
148
21
4341A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral embolism
87.2
109.5
121
16
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
193.9
100.6
103
6
C03CA01
ATC
furosemide; systemic
4.7
100.2
556
2359
C07AB07
ATC
bisoprolol; oral
4.7
99.5
616
2905
I50.9
ICD-10 Finland
Heart failure, unspecified
6.0
97.6
325
786
AA1AD
NOMESCO Finland
CT of head and brain
4.2
76.6
387
1383
I50.0
ICD-10 Finland
Congestive heart failure
6.8
72.4
202
371
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
733.4
70.0
68
*
K90
ICPC
Stroke/cerebrovascular accident
12.2
67.8
128
121
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
16.2
63.4
105
73
C07AA07
ATC
sotalol; systemic
11.7
58.5
112
108
I48.2
ICD-10 Finland
Chronic atrial fibrillation
+∞
52.6
50
*
C01BC04
ATC
flecainide; systemic
55.4
52.5
62
12
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
7.8
52.5
128
188
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.7
52.4
287
1029
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
12.7
50.8
93
81
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.8
50.0
250
826
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
+∞
49.4
47
*
I48.1
ICD-10 Finland
Persistent atrial fibrillation
165.1
45.2
47
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
8.3
44.9
104
140
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
5.6
44.9
142
294
C01BD01
ATC
amiodarone; systemic
24.6
43.8
62
27
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
43.2
222
739
R4120
NOMESCO Finland
Occupational therapy
6.6
40.4
109
183
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
146.7
40.1
42
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
4.1
38.8
170
489
B01AE07
ATC
dabigatran etexilate; oral
13.3
37.8
67
54
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
6.5
34.3
93
157
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.0
33.2
231
939
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.7
32.7
277
1272
WX892
NOMESCO Finland
Monitored bed care
4.9
32.5
114
261
XF400
NOMESCO Finland
ECG with 12 standard connections
3.0
32.4
226
916
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
5.6
32.3
99
195
XA800
NOMESCO Finland
Neuropsychological investigation
9.6
32.1
67
75
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
7.3
29.7
73
107
C10AA05
ATC
atorvastatin; oral
2.3
29.5
410
2416
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
10.8
29.3
57
56
C01DA14
ATC
isosorbide mononitrate; oral
2.5
29.3
292
1451
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
7.2
29.3
73
109
C03DA01
ATC
spironolactone; oral
3.4
29.2
159
538
XF404
NOMESCO Finland
Ambulatory ECG
4.2
28.6
116
306
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.0
28.6
124
348
C09AA05
ATC
ramipril; oral
2.4
28.0
318
1688
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
19.1
27.6
42
23
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.3
27.2
340
1882
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.5
26.5
98
236
I49.5
ICD-10 Finland
Sick sinus syndrome
6.8
26.0
67
105
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
18.2
25.9
40
23
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
12.0
25.7
47
41
H53.4
ICD-10 Finland
Visual field defects
9.1
25.3
54
63
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
23.9
215
995
B01AF01
ATC
rivaroxaban; oral
3.6
23.9
115
351
205
Kela drug reimbursment
Chronic hypertension
2.1
23.5
397
2472
I50.1
ICD-10 Finland
Left ventricular failure
4.3
23.4
92
235
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
23.2
327
1881
C01BA01
ATC
quinidine; oral
41.2
22.8
28
7
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.3
22.5
272
1454
M04AA01
ATC
allopurinol; systemic
2.6
22.2
187
830
AA5PD
NOMESCO Finland
CT examination of brain pefusion
16.8
21.5
34
21
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
21.3
390
2480
C07AB02
ATC
metoprolol; systemic
2.2
20.9
282
1574
AN1
HP
Coronary angiography
2.7
20.7
160
674
I10
ICD-10 Finland
Essential (primary) hypertension
2.0
20.6
586
4392
81
HP
Angiography of the heart and coronary arteries
3.0
20.0
123
449
B01AB05
ATC
enoxaparin; parenteral
2.1
19.8
272
1525
I50
ICD-10 Finland
Heart failure
6.0
19.6
55
97
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.4
19.1
188
899
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.5
18.9
165
740
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
9.6
18.8
38
41
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.0
18.7
313
1893
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
4.1
18.6
74
191
A46
ICD-10 Finland
Erysipelas
2.5
18.6
164
742
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
18.3
165
753
M10.9
ICD-10 Finland
Gout, unspecified
3.4
18.0
93
299
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.7
17.8
131
531
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
11.0
17.5
33
31
I42.0
ICD-10 Finland
Dilated cardiomyopathy
6.6
17.5
45
71
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
19.1
17.4
26
14
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.0
17.3
291
1753
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
17.3
115
440
I63
ICD-10 Finland
Cerebral infarction
12.9
17.2
30
24
C08DA01
ATC
verapamil; systemic
4.3
17.1
64
156
K91
ICPC
Cerebrovascular disease
8.5
17.1
37
45
R42
ICD-10 Finland
Dizziness and giddiness
2.1
17.1
228
1250
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
5.4
16.9
51
99
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
4.5
16.6
59
137
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
16.6
305
1896
C10AA01
ATC
simvastatin; oral
1.8
16.4
475
3450
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
10.7
16.3
31
30
A28
ICPC
Limited function/disability NOS
2.1
16.1
203
1082
C08CA01
ATC
amlodipine; oral
1.8
16.1
364
2428
A12BA01
ATC
potassium chloride; oral
3.0
16.0
95
337
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
8.6
15.8
34
41
R4110
NOMESCO Finland
Physiotherapy
2.0
15.6
223
1253
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
9.7
15.0
30
32
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
6.4
15.0
39
63
R06.0
ICD-10 Finland
Dyspnoea
2.0
14.8
224
1282
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.5
14.6
122
531
43499
ICD-8 Finland
Cerebral embolism, Without mention of hypertension
81.4
14.6
16
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
8.6
14.6
31
37
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
11.1
14.6
27
25
C09AA02
ATC
enalapril; systemic
1.9
14.2
248
1493
K99
ICPC
Cardiovascular disease other
5.9
14.0
39
69
PA7BD
NOMESCO Finland
CT angiography of neck and brain
6.7
14.0
35
54
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
13.9
93
356
N18
ICPC
Paralysis/weakness
5.5
13.9
41
78
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
3.9
13.6
56
150
I63.8
ICD-10 Finland
Other cerebral infarction
8.5
13.6
29
35
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
13.5
107
452
N02BE01
ATC
paracetamol; systemic, rectal
1.8
13.3
667
5567
WX872
NOMESCO Finland
Intensive care
3.6
13.3
61
180
R04.0
ICD-10 Finland
Epistaxis
2.8
13.2
88
336
L28
ICPC
Limited function/disability (L)
2.1
13.1
173
931
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.4
13.1
118
534
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.6
13.1
98
402
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.5
13.0
62
188
K77
ICPC
Heart failure
6.0
12.9
35
60
R4150
NOMESCO Finland
Neuropsychological rehabilitation
22.9
12.9
18
8
B01AF03
ATC
edoxaban; oral
22.9
12.9
18
8
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.8
12.8
83
312
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
12.8
311
2079
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
5.7
12.8
36
65
R1260
NOMESCO Finland
Evaluation of communicative skills
5.4
12.5
37
71
B01AC04
ATC
clopidogrel; oral
1.9
12.5
195
1121
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.4
12.2
110
499
SPAT1251
SPAT
Organisation of medication
3.6
12.1
54
156
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
27.1
12.1
16
6
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.7
12.0
85
336
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.2
11.9
125
609
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
47.3
11.9
14
*
C09AA04
ATC
perindopril; oral
3.0
11.9
69
242
R53
ICD-10 Finland
Malaise and fatigue
1.9
11.8
186
1072
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.8
11.5
48
131
342
Kela drug reimbursment
Dronedarone
+∞
11.5
11
*
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
121.4
11.4
12
*
43400
ICD-8 Finland
Cerebral embolism, With hypertension (benign)
121.4
11.4
12
*
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
11.4
431
5370
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.9
11.2
69
251
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.2
11.1
24
30
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
11.1
142
754
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
3.0
11.1
64
224
TFP34
NOMESCO Finland
Electrophysiological investigation
11.3
11.1
20
18
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
9.4
11.0
22
24
C03AA03
ATC
hydrochlorothiazide; oral
2.2
11.0
114
552
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
9.0
10.8
22
25
3A064
NOMESCO Finland
NA
60.7
10.6
12
*
C01BC03
ATC
propafenone; systemic
60.7
10.6
12
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
10.6
97
441
N19
ICPC
Speech disorder
6.0
10.5
28
48
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.7
10.4
45
127
C01BD07
ATC
dronedarone; oral
+∞
10.4
10
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
10.4
52
165
SPAT1263
SPAT
Sampling
1.7
10.3
308
2161
C09DX04
ATC
valsartan and sacubitril; oral
23.7
10.3
14
6
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
10.1
218
1385
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
10.1
138
748
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
6.6
10.1
25
39
SPAT1252
SPAT
Overall medication plan or its review
2.5
10.0
82
352
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
9.9
119
612
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
9.9
246
1634
K22
ICPC
Risk factor cardiovascular disease
3.1
9.9
52
172
I25.2
ICD-10 Finland
Old myocardial infarction
2.2
9.8
108
535
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
9.8
76
318
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
9.8
104
509
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
3.1
9.8
52
173
WX002
NOMESCO Finland
Sedation and analgesia
1.9
9.8
162
945
C07AB03
ATC
atenolol; systemic
2.4
9.7
83
364
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.2
9.5
95
452
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
9.5
279
1937
SPAT1254
SPAT
Administration of medicine
1.9
9.4
142
797
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.7
9.4
66
259
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
9.4
127
686
S97
ICPC
Chronic ulcer skin
2.7
9.4
62
236
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
9.3
143
807
B01AC07
ATC
dipyridamole; systemic
2.1
9.2
104
521
ZX120
NOMESCO Finland
Intravenous
2.3
9.2
86
397
K80
ICPC
Cardiac arrhythmia NOS
2.9
9.2
54
193
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
9.0
57
212
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
4.3
8.9
32
77
R4130
NOMESCO Finland
Speech therapy
4.3
8.9
32
77
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
8.8
57
216
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
8.8
63
252
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
8.8
123
674
J01DB01
ATC
cefalexin; oral
1.6
8.8
570
4766
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.4
8.7
71
304
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
50.4
8.7
10
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
5.1
8.7
26
52
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
3.5
8.7
39
115
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
8.7
69
294
R51.80
ICD-10 Finland
Headache
2.3
8.7
84
393
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.8
8.6
55
208
A10AE04
ATC
insulin glargine; parenteral
2.2
8.5
86
411
R50.9
ICD-10 Finland
Fever, unspecified
2.0
8.5
115
622
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.3
8.5
76
345
11
HP
Coronary artery bypass surgery
3.0
8.4
46
157
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.5
8.4
67
286
AS2
HP
Ventricular pacemaker insertion VVI (R)
12.9
8.4
14
11
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
8.3
119
654
AR6
HP
Catheter ablation of arrhythmia, target: atrial fibrillation
+∞
8.3
8
*
K92.1
ICD-10 Finland
Melaena
2.5
8.3
66
279
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
10.9
8.3
15
14
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.6
8.3
58
231
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.4
8.2
39
120
WX882
NOMESCO Finland
High dependency care
4.0
8.2
31
79
R02
ICPC
Shortness of breath/dyspnoea
2.1
8.2
90
446
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
8.2
141
832
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.6
8.2
57
227
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
8.1
68
298
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
8.1
284
2048
K50
ICPC
Cardiovascular, Medication/prescr/renewal
22.2
8.0
11
5
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.6
8.0
55
216
A10BA02
ATC
metformin; oral
1.6
7.9
266
1896
N06AX11
ATC
mirtazapine; oral
1.6
7.9
212
1425
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
7.7
57
234
XF402
NOMESCO Finland
ECG with work load test
2.0
7.7
97
507
4278A
ICD-9 Finland
Cardiac dysrhythmias, Other specified cardiac dysrhythmias[SICK SINUS-SYNDROMA]
45.3
7.7
9
*
K29
ICPC
Cardiovascular sympt/complt other
3.0
7.7
42
144
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.8
7.6
46
169
SPAT1216
SPAT
Assessment of functional ability
1.7
7.6
158
987
XF640
NOMESCO Finland
NA
3.4
7.5
35
107
C07AG02
ATC
carvedilol; oral
2.3
7.5
70
324
FPJ02
NOMESCO Finland
Revision of ventricular pacemaker generator
80.7
7.4
8
*
R00.1
ICD-10 Finland
Bradycardia, unspecified
3.1
7.4
39
131
A06AD11
ATC
lactulose; oral
1.7
7.3
184
1211
M01AH05
ATC
etoricoxib; oral
0.6
7.3
194
2698
41201
ICD-8 Finland
Chronic ischaemic heart disease, Status post infarctum cordis, cum hypertonia
11.0
7.3
13
12
TFP47
NOMESCO Finland
Ablation or modification of the AV-node
+∞
7.3
7
*
Z50.5
ICD-10 Finland
Speech therapy
5.9
7.2
19
33
ZXA05
NOMESCO Finland
Left side
1.6
7.2
220
1528
M10.0
ICD-10 Finland
Idiopathic gout
3.2
7.2
36
117
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
7.1
204
1393
GD1LA
NOMESCO Finland
GD
7.1
7.0
16
23
-34
ICPC
Blood test
3.9
7.0
27
71
SPAT1301
SPAT
No procedures
1.5
7.0
253
1826
A02BC02
ATC
pantoprazole; systemic
1.5
6.9
474
3910
K05
ICPC
Irregular heartbeat other
4.3
6.9
24
57
C02AC05
ATC
moxonidine; oral
2.7
6.9
46
179
61
HP
Catheterization and pressure measurement of the left side of the heart
3.3
6.9
32
98
RD211
NOMESCO Finland
NA
3.0
6.9
37
126
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
13.9
6.9
11
8
T90
ICPC
Diabetes non-insulin dependent
1.6
6.9
188
1264
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
3.7
6.8
28
78
H02AB06
ATC
prednisolone; systemic
1.5
6.8
352
2740
K84
ICPC
Heart disease other
3.9
6.8
26
68
AQ2
HP
Electrophysiological electroanatomical examination
40.3
6.8
8
*
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
16.8
6.7
10
6
WX730
NOMESCO Finland
Conventional respirator
4.8
6.7
21
45
Z71.8
ICD-10 Finland
Other specified counselling
1.7
6.7
143
899
73
HP
Initial pacemaker installation
7.2
6.7
15
21
5273
FHL
Repair with flap prosthesis or graft
22.7
6.7
9
*
K83
ICPC
Heart valve disease NOS
7.9
6.6
14
18
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
6.6
38
134
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.1
6.6
75
379
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.6
122
733
C01BA03
ATC
disopyramide; systemic
8.8
6.6
13
15
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.1
6.5
12
12
W19
ICD-10 Finland
Unspecified fall
2.0
6.5
83
440
A04
ICPC
Weakness/tiredness general
1.8
6.5
106
611
PA6AD
NOMESCO Finland
CT of neck arteries
5.4
6.5
18
34
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.5
177
1192
N19
ICD-10 Finland
Unspecified kidney failure
2.7
6.4
42
162
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.5
6.4
14
19
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.5
6.4
14
19
I20.00
ICD-10 Finland
Unstable angina
2.6
6.4
43
169
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.4
6.4
51
218
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.0
6.4
19
39
N28
ICPC
Limited function/disability (N)
3.9
6.3
24
63
AQ1
HP
Conventional electrophysiological examination
11.1
6.3
11
10
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.5
6.3
46
190
TFP32
NOMESCO Finland
Cathetric treatmen of cardiac arrythmia
18.1
6.3
9
5
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.7
6.2
41
159
I20.01
ICD-10 Finland
Unstable angina
2.7
6.2
40
151
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
26.8
6.2
8
*
C08DB01
ATC
diltiazem; oral
2.0
6.2
82
440
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
5.1
6.2
18
36
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.2
6.2
30
96
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
6.1
161
1069
I20.91
ICD-10 Finland
Angina pectoris, unspecified
4.3
6.1
21
50
WX722
NOMESCO Finland
PEEP
2.6
6.1
43
171
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
6.1
105
618
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.8
6.1
24
65
SPAT1229
SPAT
Assessment of need for aid
1.9
6.1
81
435
R40.0
ICD-10 Finland
Somnolence
12.6
6.1
10
8
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
6.1
64
312
ZXA00
NOMESCO Finland
Right side
1.5
6.0
221
1590
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
3.7
6.0
24
66
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
5.6
6.0
16
29
42798
ICD-8 Finland
Symptomatic heart disease, Alia arrhytmia definita
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027456) Digoxin [Moles/volume] in Serum or Plasma
96
31
34.17
148.95
3.3
2.1
nmol/l
0.9
1.0
0.31
76
18
(3022217) INR in Platelet poor plasma by Coagulation assay
295
740
5.26
114.04
47.5
13.9
inr
2.1
1.2
9.34
32
126
(3018677) aPTT in Platelet poor plasma by Coagulation assay
349
1031
4.69
109.83
2.9
1.9
s
31.0
28.8
7.18
337
1004
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
130
209
7.01
79.21
3.4
2.5
u/ml
0.4
0.3
0.43
86
115
(3032080) INR in Blood by Coagulation assay
560
2791
3.32
74.90
22.3
5.4
inr
1.7
1.1
21.44
169
724
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
441
2028
3.12
65.52
2.8
2.1
u/l
201.7
262.2
0.57
430
1879
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
194
669
3.36
44.97
3.9
2.5
ng/l
386.7
213.4
3.65
179
601
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
291
1323
2.70
40.69
6.5
3.6
ng/l
143.4
386.7
2.10
271
1160
(3036489) Thrombin time
83
166
5.36
39.89
2.3
2.0
s
21.3
21.4
0.02
75
152
(3023368) Bacteria identified in Blood by Culture
389
2108
2.39
36.77
5.1
4.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
405
2259
2.34
35.56
4.6
2.5
ng/l
3232.2
1340.4
8.28
365
1911
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
200
815
2.82
33.97
6.3
5.9
kpa
5.0
5.1
1.41
183
770
(3027801) Oxygen [Partial pressure] in Arterial blood
200
815
2.82
33.97
6.3
5.9
kpa
11.2
11.9
1.15
182
767
(3022948) Iron [Moles/volume] in Serum or Plasma
234
1047
2.62
32.99
3.0
2.4
umol/l
10.0
12.5
7.19
215
959
(3004789) Transferrin [Mass/volume] in Serum or Plasma
219
953
2.67
32.63
3.0
2.4
g/l
2.3
2.2
0.26
205
866
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
211
903
2.70
32.48
3.0
2.5
%
17.9
22.9
6.57
173
749
(3003396) Base excess in Arterial blood by calculation
195
814
2.74
31.45
6.4
5.9
mmol/l
1.3
1.2
0.09
156
618
(3016502) Oxygen saturation in Arterial blood
182
738
2.80
31.01
6.4
6.1
%
95.4
95.3
0.09
167
711
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
193
853
2.57
27.47
2.2
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
192
852
2.55
27.07
2.3
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
158
659
2.66
25.17
2.7
2.2
ug/l
6.4
5.7
0.22
133
537
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
238
1210
2.27
24.54
2.3
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
157
675
2.57
23.43
6.9
6.5
g/l
117.1
119.3
0.61
149
650
(3012095) Magnesium [Moles/volume] in Serum or Plasma
204
1031
2.23
21.02
4.0
2.8
mmol/l
0.8
0.8
0.09
188
943
(3000991) Gas panel - Venous blood
133
556
2.61
20.92
7.3
6.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
139
600
2.53
20.45
9.5
5.4
mmol/l
12.7
11.4
0.96
134
569
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
315
1891
1.98
20.44
2.7
2.1
mg/l
3.1
3.0
0.36
272
1578
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
101
377
2.87
19.75
7.4
7.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
24
27
9.08
19.47
6.0
7.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
545
3984
1.82
18.53
6.8
4.2
mmol/l
7.0
7.0
0.41
524
3729
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
95
361
2.80
17.95
6.7
7.5
mmol/l
24.9
24.6
0.33
88
327
(3007853) Bacteria identified in Skin by Aerobe culture
152
725
2.29
17.80
2.2
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
116
494
2.53
17.47
5.0
4.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
130
586
2.40
17.31
6.3
5.5
mmol/l
1.4
1.3
0.39
123
553
(3021447) Carbon dioxide [Partial pressure] in Venous blood
145
692
2.28
16.92
4.5
3.1
kpa
5.9
5.8
0.54
140
668
(3014576) Chloride [Moles/volume] in Serum or Plasma
174
895
2.14
16.88
6.9
5.9
mmol/l
103.7
104.1
0.50
169
877
(3002032) Base excess in Venous blood by calculation
144
691
2.27
16.57
4.5
3.1
mmol/l
2.0
1.9
0.10
118
517
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
89
349
2.70
15.81
1.5
1.8
g/l
1.6
1.6
0.07
77
296
(3026008) Bacteria identified in Urine by Culture
350
2323
1.78
15.76
4.2
3.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
106
465
2.43
14.93
7.4
5.9
mmol/l
24.5
24.4
0.04
95
435
(3003458) Phosphate [Moles/volume] in Serum or Plasma
170
906
2.06
14.90
6.7
4.6
mmol/l
1.1
1.0
1.87
159
829
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
399
2810
1.70
14.20
6.0
3.6
ng/l
46.7
77.9
1.04
338
2193
(3042936) Bacteria identified in Isolate by Culture
168
908
2.02
14.13
2.1
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
111
513
2.31
13.89
1.8
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
76
302
2.64
13.15
4.8
3.5
mmol/l
24.7
23.9
1.01
70
268
(3001122) Ferritin [Mass/volume] in Serum or Plasma
346
2383
1.69
13.14
3.6
2.6
ug/l
136.8
166.7
2.25
318
2116
(3030467) Casts [#/volume] in Urine by Automated count
303
2016
1.72
13.05
4.0
3.3
e6/l
0.6
0.5
0.24
247
1572
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
412
2992
1.65
12.63
4.7
4.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
56
194
3.00
12.51
5.1
3.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
288
1909
1.72
12.48
4.0
3.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
412
3003
1.64
12.38
6.1
5.1
e9/l
1.7
1.9
3.37
367
2597
(3023183) Ammonium ion [Moles/volume] in Plasma
40
113
3.64
12.36
1.6
2.6
umol/l
26.0
34.3
1.84
33
95
(3024561) Albumin [Mass/volume] in Serum or Plasma
422
3099
1.63
12.27
5.6
4.5
g/l
32.7
34.4
7.71
392
2840
(3002582) Erythrocytes [#/volume] in Urine
322
2211
1.68
12.18
4.0
3.5
e6/l
157.6
84.2
0.37
261
1747
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
465
3508
1.61
12.04
9.1
6.0
mmol/l
1.2
1.2
5.90
406
2920
(3001604) Monocytes [#/volume] in Blood
401
2919
1.63
12.01
6.0
5.0
e9/l
0.7
0.6
2.65
351
2471
(3031040) Bacteria [#/volume] in Urine by Automated count
563
4459
1.61
11.82
6.3
5.0
e6/l
394.2
1059.0
—
5
78
(3006315) Basophils [#/volume] in Blood
401
2934
1.62
11.68
6.1
5.0
e9/l
0.0
0.0
0.18
355
2500
(3022096) Basophils/100 leukocytes in Blood
374
2716
1.61
11.09
6.5
5.2
%
0.6
0.6
0.98
364
2489
(3044640) Blood type and Crossmatch panel - Blood
305
2113
1.64
10.93
2.9
2.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
151
856
1.90
10.91
3.1
3.7
u/l
252.5
246.5
0.27
138
795
(3013115) Eosinophils [#/volume] in Blood
407
3031
1.58
10.76
6.2
5.1
e9/l
0.2
0.2
0.22
365
2610
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
358
2587
1.60
10.76
4.2
3.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
301
2098
1.62
10.44
4.7
3.8
ph
7.4
7.4
0.45
49
397
(3023520) Reticulocytes [#/volume] in Blood
126
687
1.95
10.20
2.2
2.3
e9/l
73.1
63.6
1.79
91
535
(3027945) Reticulocytes/100 erythrocytes in Blood
160
944
1.83
10.16
2.2
2.1
%
1.9
1.7
1.46
143
827
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
71
313
2.36
9.88
5.2
4.1
%
1.7
1.7
0.08
64
297
(3019069) Monocytes/100 leukocytes in Blood
377
2801
1.56
9.84
6.8
5.5
%
9.4
8.9
2.35
365
2573
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
416
3164
1.54
9.75
7.9
5.3
mmol/l
1.2
1.2
5.45
388
2803
(3006504) Eosinophils/100 leukocytes in Blood
375
2790
1.55
9.69
6.6
5.2
%
2.7
2.9
0.85
365
2556
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
193
1223
1.72
9.56
3.5
2.9
e6/l
1.2
1.5
0.44
111
745
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
184
1153
1.73
9.48
3.7
3.1
e6/l
2.9
2.1
0.41
101
682
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
91
457
2.09
9.24
2.4
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
235
1582
1.64
9.22
2.7
2.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
69
310
2.32
9.21
5.4
4.2
%
0.9
0.9
0.21
62
294
(3018010) Neutrophils/100 leukocytes in Blood
375
2814
1.53
9.21
6.6
5.3
%
61.6
59.0
4.25
366
2587
(3018095) Leukocytes [#/volume] in Urine
338
2487
1.54
9.04
4.7
3.9
e6/l
80.3
148.1
1.05
267
1861
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
61
262
2.41
9.01
2.0
2.4
ug/l
493.2
620.2
0.19
61
248
(3037467) Urinalysis macro (dipstick) panel - Urine
551
4497
1.51
9.00
6.0
4.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
379
2863
1.52
8.96
6.8
5.5
%
22.4
25.6
7.59
369
2608
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
436
3398
1.51
8.86
6.0
6.0
umol/l
15.2
12.0
2.96
420
3187
(3013650) Neutrophils [#/volume] in Blood by Automated count
444
3481
1.50
8.72
8.4
8.2
e9/l
4.7
4.4
1.46
394
3009
(3051651) Icteric interference index of Serum or Plasma
19
40
4.82
8.60
5.9
4.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
85
428
2.08
8.57
1.7
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
43
163
2.71
8.21
6.3
5.7
mmol/l
102.1
105.1
2.42
36
148
(3039000) Anion gap in Blood
43
163
2.71
8.21
6.3
5.7
mmol/l
11.2
11.0
0.18
36
148
(3045788) Cell count panel - Pleural fluid
26
73
3.63
8.16
1.5
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
284
2050
1.54
8.14
5.7
5.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
24
65
3.76
7.93
3.8
3.7
umol/l
338.0
334.2
0.04
19
53
(3024928) Oxygen saturation in Venous blood
36
128
2.88
7.75
2.9
2.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
227
1574
1.57
7.73
2.8
2.7
e6/l
4.9
4.5
0.22
212
1384
(3026493) Urate [Moles/volume] in Serum or Plasma
235
1643
1.56
7.71
3.6
2.7
umol/l
397.5
8664.2
7.34
191
1358
(3026782) Osmolality of Urine
222
1533
1.58
7.69
3.1
2.9
mosm/kgh2o
526.3
569.4
2.86
201
1292
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
118
696
1.79
7.44
2.1
2.7
umol/l
11.2
10.9
0.04
105
605
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
245
1759
1.52
7.06
3.2
3.0
u/l
42.6
35.4
1.00
226
1674
(3047181) Lactate [Moles/volume] in Blood
51
227
2.31
7.00
6.6
5.1
mmol/l
1.4
1.3
0.50
44
198
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
166
2.53
6.91
1.4
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
98
561
1.83
6.82
2.5
2.4
u/l
40.1
38.6
0.06
83
462
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
413
3311
1.42
6.67
3.5
3.0
u/l
70.8
54.2
1.92
390
2963
(3051611) Lipemic interference index of Serum or Plasma
24
74
3.30
6.58
5.5
3.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
63
315
2.07
6.51
2.0
1.7
ug/l
2.7
2.3
0.09
52
264
(3003434) Protein [Mass/volume] in Pleural fluid
29
101
2.93
6.51
1.3
1.3
g/l
24.0
32.7
2.79
22
92
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
55
3.69
6.49
1.2
1.2
u/ml
3.5
8.3
0.63
11
26
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
19
51
3.78
6.38
1.3
1.2
u/ml
18.3
7.4
—
9
14
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
38
156
2.49
6.24
1.4
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
27
95
2.89
5.97
1.4
1.2
e6/l
4890.6
1980.9
0.43
16
71
(4268621)
15
36
4.21
5.83
2.0
2.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
45
206
2.24
5.83
3.0
3.2
pmol/l
4.2
4.5
0.81
40
175
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
86
2.95
5.75
1.3
1.2
e6/l
55975.1
68467.6
0.14
14
53
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
100
608
1.72
5.68
1.6
2.1
g/l
0.2
0.2
2.55
90
556
(3009508) Creatinine [Moles/volume] in Urine
273
2079
1.43
5.68
3.1
3.1
mmol/l
6.7
7.3
1.61
233
1674
(3036782) Glucose [Moles/volume] in Pleural fluid
23
76
3.07
5.67
1.4
1.3
mmol/l
8.6
6.3
1.23
18
68
(3019309) Folate [Moles/volume] in Red Blood Cells
236
1755
1.45
5.56
1.8
1.8
nmol/l
1164.9
1151.4
0.07
189
1300
(3044889) 12 lead EKG panel
525
4475
1.37
5.51
5.9
3.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
93
559
1.73
5.50
4.3
3.4
ng/l
120.2
90.7
2.06
82
471
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
316
2484
1.40
5.45
2.8
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
249
1877
1.44
5.45
1.7
1.6
nmol/l
17.8
19.9
1.70
226
1564
(3012441) Differential panel - Pleural fluid
22
74
3.02
5.27
1.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
271
2086
1.41
5.25
3.4
3.2
mg/l
905.0
251.0
0.93
205
1331
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
36
157
2.34
5.23
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
36
157
2.34
5.23
1.5
1.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
31
4.23
5.09
1.7
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
285
2231
1.39
4.97
3.6
3.9
mg/mmol
17.3
10.4
1.14
208
1425
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
498
4255
1.34
4.93
3.8
3.5
pmol/l
15.5
15.1
2.59
447
3658
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
49
249
2.02
4.91
1.5
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
104
1563
0.63
4.89
3.4
3.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
49
250
2.01
4.85
2.8
3.1
mg/l
37.4
61.4
0.96
43
206
(3034860) Kappa light chains.free [Mass/volume] in Serum
49
251
2.00
4.80
2.8
3.0
mg/l
55.8
74.3
0.47
42
206
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
382
3147
1.35
4.79
2.5
2.1
pmol/l
87.9
92.4
1.15
222
1627
(3052592) Norovirus Ag [Presence] in Stool
9
10
9.06
4.79
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
175
1263
1.47
4.77
2.1
1.6
mg/l
1.4
1.7
0.94
134
1008
(3044941) Cell count panel - Synovial fluid
25
96
2.64
4.75
1.2
1.4
—
—
—
0
0
(44790048)
20
69
2.94
4.61
1.8
1.5
—
—
—
0
0
(44790049)
20
69
2.94
4.61
1.8
1.5
—
—
—
0
0
(44790047)
20
69
2.94
4.61
1.8
1.5
—
—
—
0
0
(44806118)
20
69
2.94
4.61
1.8
1.5
—
—
—
0
0
(3020891) Body temperature
54
293
1.89
4.50
6.3
3.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
195
1453
1.43
4.47
4.6
4.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
66
383
1.77
4.45
2.3
2.7
g/l
11.3
11.0
0.09
61
333
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
47
246
1.95
4.36
2.8
3.0
ratio
4.5
2.4
—
6
20
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
46
3.29
4.19
1.3
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
673
6085
1.33
4.16
31.4
15.9
mg/l
28.4
29.3
0.29
629
4944
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
561
4953
1.31
4.08
8.6
7.2
u/l
86.5
81.4
1.17
533
4572
(3009261) Glucose [Presence] in Urine by Test strip
371
3110
1.31
3.93
4.9
4.2
estimate
0.0
0.0
0.00
81
571
(3002179) Metamyelocytes/100 leukocytes in Blood
74
463
1.65
3.83
3.4
4.2
%
0.3
0.6
1.11
14
122
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
253
2016
1.34
3.81
2.5
2.4
u/l
64.8
57.5
1.12
240
1835
(3035350) Ketones [Presence] in Urine by Test strip
365
3072
1.30
3.70
4.9
4.1
estimate
0.0
0.0
0.00
82
582
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
50
3.03
3.69
1.3
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
97
2.40
3.66
5.6
5.3
iu/ml
125.7
245.6
—
7
11
(40758558) Short blood count panel - Blood
193
1484
1.37
3.65
7.7
6.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
537
4754
1.28
3.64
36.9
20.0
%
14.6
13.9
13.92
524
4608
(3000475) Leukocytes [#/volume] in Synovial fluid
32
156
2.09
3.64
1.6
1.6
e6/l
14410.3
19502.5
0.41
24
107
(3013707) Erythrocyte sedimentation rate by Westergren method
522
4608
1.28
3.61
5.0
4.0
mm/h
17.6
14.8
3.08
501
4139
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
17
5.33
3.51
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
17
5.33
3.51
1.2
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
44
244
1.84
3.49
2.7
2.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
20
81
2.50
3.47
1.4
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
360
3053
1.28
3.37
6.7
5.6
estimate
0.0
0.0
0.49
78
578
(3003338) MCHC [Mass/volume]
539
4801
1.27
3.37
41.7
21.6
g/l
329.0
331.5
6.50
524
4722
(36660697) Celiac disease serology panel - Serum
56
339
1.69
3.31
1.1
1.2
—
—
—
0
0
(4306422)
14
48
2.94
3.30
1.1
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
48
2.94
3.30
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
18
72
2.53
3.22
1.2
1.3
mu/l
120.3
52.1
0.69
12
63
(3021589) Normoblasts [#/volume] in Blood
315
2640
1.28
3.21
12.2
9.6
e9/l
0.0
0.0
0.27
263
2172
(3025159) Blasts/100 leukocytes in Blood
71
464
1.57
3.12
3.9
4.2
%
0.0
0.2
1.44
18
127
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
50
2.82
3.09
1.8
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
590
5342
1.26
3.08
5.2
4.4
mu/l
2.0
2.1
0.95
550
4627
(40760888) Immunoglobulin light chains.free panel - Serum
35
188
1.89
3.08
3.0
3.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
106
2.20
3.04
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
126
2.09
3.04
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
28
140
2.03
3.02
1.6
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
21
4.31
2.99
1.3
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
51
2.77
2.99
1.3
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
51
2.77
2.99
1.8
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
12
40
3.02
2.97
1.4
1.7
u/field
1.7
3.7
—
6
25
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
40
3.02
2.97
1.0
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
40
3.02
2.97
1.0
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
144
1.97
2.81
1.6
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
18
4.47
2.79
1.6
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
59
381
1.58
2.75
5.1
3.4
%
49.9
47.3
0.39
59
375
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
19
4.23
2.68
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
93
668
1.43
2.63
2.0
2.2
g/l
65.7
65.9
0.07
82
589
(3036481) Cortisol [Moles/volume] in Serum or Plasma
73
501
1.49
2.60
2.0
2.1
nmol/l
404.3
369.8
0.67
64
449
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
65
436
1.52
2.58
5.0
3.2
kpa
5.0
5.1
0.75
58
400
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
62
412
1.54
2.57
5.1
3.1
mmol/l
0.5
1.7
1.70
43
286
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
135
1.95
2.56
1.3
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
72
495
1.49
2.55
3.8
4.2
%
0.0
0.1
0.97
21
158
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
11
5.48
2.54
1.2
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
15
62
2.44
2.54
1.3
1.2
u/l
8.1
13.1
—
10
57
(3017181) Myelocytes/100 leukocytes in Blood
76
533
1.46
2.45
3.8
4.1
%
0.5
0.9
1.68
21
173
(3009343) pH of Capillary blood
64
435
1.50
2.41
5.1
3.2
ph
7.4
7.4
—
5
53
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
67
460
1.49
2.40
4.7
2.9
ml/min/173m2
47.8
58.5
3.01
36
192
(3033799) Differential panel - Peritoneal fluid
6
12
5.02
2.40
1.2
2.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
60
403
1.52
2.39
2.0
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
77
2.23
2.38
2.1
2.6
—
681.2
—
0
6
(3034426) Prothrombin time (PT)
5
8
6.27
2.37
1.2
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
12
46
2.63
2.36
3.2
2.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
17
4.14
2.36
1.3
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
98
2.06
2.32
2.7
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
83
599
1.42
2.31
4.7
3.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
59
398
1.51
2.31
2.2
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
14
59
2.39
2.29
1.2
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
92
2.08
2.28
1.5
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
9
5.57
2.21
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
62
428
1.48
2.19
1.7
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
14
4.30
2.15
1.2
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
11
43
2.57
2.10
1.4
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
62
2.27
2.08
4.4
2.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
77
562
1.40
2.04
2.0
2.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
16
76
2.12
2.03
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
32
2.83
2.00
2.2
2.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
584
5410
1.19
1.99
4.5
4.1
mmol/l
1.2
1.3
1.29
541
4682
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
11
4.56
1.94
5.0
7.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
16
3.76
1.93
1.5
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
277
2410
1.21
1.88
2.8
3.3
mmol/l
2.3
2.3
0.14
241
2038
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
65
2.17
1.88
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
22
3.19
1.88
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
21
114
1.86
1.88
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
79
2.04
1.85
2.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
46
2.41
1.85
1.5
1.4
%
9.5
10.7
0.31
11
46
(3004451) EKG impression Narrative
10
40
2.51
1.83
1.9
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
108
1.87
1.82
1.2
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
59
812
0.71
1.81
6.0
4.7
%
36.0
33.5
1.00
54
486
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
80
2.02
1.80
1.4
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
321
1.49
1.79
2.4
1.8
g/l
3.5
3.7
0.50
33
221
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
289
1.51
1.77
2.5
1.8
g/l
3.2
3.3
0.10
35
224
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
322
1.48
1.76
2.4
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
322
1.48
1.76
2.4
1.8
g/l
7.4
7.7
0.44
34
224
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
102
1.88
1.76
1.3
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
41
2.45
1.75
3.0
2.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
81
1.99
1.75
1.1
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
18
3.34
1.74
1.0
2.6
%
94.7
86.9
—
6
18
(3007164) IgA [Mass/volume] in Serum or Plasma
113
898
1.29
1.74
1.4
1.4
g/l
2.9
2.8
0.17
63
489
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
307
1.49
1.73
2.4
1.8
g/l
10.5
10.3
0.09
38
254
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
24
2.93
1.72
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
283
1.50
1.71
1.4
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
78
590
1.35
1.70
1.4
1.3
titre
334.1
427.0
0.40
17
135
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
55
2.19
1.67
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
178
1501
1.23
1.65
2.7
3.1
mmol/l
2.5
2.5
2.42
149
1309
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
83
1.94
1.65
1.4
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
49
2.26
1.63
1.4
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
143
1.69
1.62
1.4
2.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
91
1.88
1.61
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
599
5615
1.17
1.60
5.1
4.6
mmol/l
1.3
1.4
22.80
561
4914
(3019150) Specific gravity of Urine by Refractometry
168
1418
1.22
1.55
5.5
4.6
kg/l
1.0
1.0
2.21
24
245
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
64
2.04
1.54
1.2
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
10
44
2.28
1.53
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
64
479
1.36
1.51
1.9
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
86
1.87
1.50
1.6
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
21
2.87
1.50
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
58
2.08
1.49
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
37
2.44
1.48
1.7
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
170
1445
1.21
1.47
1.3
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
45
2.23
1.46
1.7
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
111
1.72
1.39
1.4
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
29
2.42
1.39
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
190
1.54
1.38
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
89
1.81
1.37
2.8
3.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
89
1.81
1.37
1.3
2.1
u/field
0.6
2.6
—
5
21
(3022493) Free Hemoglobin [Mass/volume] in Plasma
6
23
2.62
1.36
7.0
1.7
mg/l
68.5
77.5
—
6
18
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
283
2531
1.16
1.36
2.4
2.1
nmol/l
76.7
79.1
0.72
244
2140
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
17
2.95
1.36
1.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
27
175
1.56
1.35
1.6
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
257
1.46
1.35
1.5
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
653
6203
1.15
1.34
28.7
15.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
42
2.15
1.33
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
144
1.61
1.32
1.7
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
603
5700
1.15
1.31
5.3
4.6
mmol/l
3.7
4.4
53.83
573
5044
(3009542) Hematocrit [Volume Fraction] of Blood
549
5157
1.14
1.31
36.2
18.1
%
38.1
37.4
0.98
327
3001
(3044242) Glucose [Moles/volume] in Arterial blood
8
34
2.36
1.29
2.1
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
18
2.78
1.28
1.4
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
62
1.95
1.28
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
99
1.73
1.27
1.3
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
40
287
1.41
1.25
2.0
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
119
0.42
1.24
1.8
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
171
1.53
1.24
1.8
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
732
1.25
1.20
1.2
1.2
u/ml
18.1
16.8
0.05
26
247
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
101
1.69
1.20
2.9
2.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
212
2384
0.86
1.19
2.2
2.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
109
1.66
1.19
1.2
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
109
1.66
1.19
1.2
1.2
u/ml
71.6
3.1
—
5
12
(3000494) Fungus identified in Specimen by Culture
86
699
1.25
1.16
1.5
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
20
2.51
1.15
1.0
1.1
iu/ml
259.0
204.2
—
5
20
(3032057) Clostridioides difficile [Presence] in Stool
5
20
2.51
1.15
2.4
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
198
1747
1.17
1.13
5.8
4.3
estimate
0.0
0.0
0.00
73
546
(4035726)
43
571
0.74
1.13
1.8
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
680
6512
1.14
1.13
39.3
18.8
mmol/l
139.3
139.5
1.13
660
6271
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
103
1.66
1.13
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
30
2.34
1.12
2.6
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
30
2.34
1.12
2.6
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
18
111
1.63
1.12
1.2
1.2
u/ml
5.9
2.1
—
6
17
(21494890) Protein electrophoresis panel - 24 hour Urine
13
73
1.79
1.11
1.8
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
43
320
1.36
1.11
5.5
3.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
31
2.27
1.10
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
339
0.67
1.10
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
37
269
1.39
1.09
2.0
1.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
21
2.39
1.09
1.4
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
21
2.39
1.09
1.4
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
21
2.39
1.09
1.4
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
21
2.39
1.09
1.4
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
680
6522
1.13
1.07
39.5
18.9
mmol/l
4.0
4.0
0.04
660
6279
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
67
1.80
1.04
2.4
3.5
%
66.6
57.2
—
7
42
(40760892) CBC W Ordered Manual Differential panel - Blood
134
1154
1.19
1.04
4.4
4.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
98
1.64
1.03
1.6
1.6
iu/l
2.9
7.2
—
5
26
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
34
2.06
1.03
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
189
0.58
1.01
2.2
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
35
256
1.38
1.01
1.3
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
48
1.88
1.00
2.2
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
37
274
1.36
1.00
2.2
1.9
g/l
1.5
1.4
0.04
32
226
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
164
1.47
0.99
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
165
1.46
0.97
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
165
1.46
0.97
1.3
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
100
1.61
0.97
1.4
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
31
225
1.39
0.95
2.8
2.6
g/l
0.4
0.3
0.51
15
80
(3037756) Immunofixation for Serum or Plasma
24
166
1.46
0.94
1.5
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
660
6343
1.12
0.93
13.8
10.4
u/l
28.3
23.8
0.79
638
5982
(1616796) Gas panel - Central venous blood
22
150
1.48
0.93
4.9
4.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
78
1.67
0.91
1.7
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
614
5887
1.11
0.88
6.2
5.2
mmol/l
2.0
2.5
52.90
582
5184
(3013512) EKG study
187
2075
0.88
0.88
6.3
4.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
1.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
1.4
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
1.4
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
43
1.87
0.87
1.6
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
72
1.67
0.85
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.2
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
593
5684
1.11
0.84
7.5
6.6
mmol/mol
43.1
41.3
3.74
560
5070
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
90
766
1.19
0.82
1.2
1.3
iu/ml
39.1
42.9
0.09
28
248
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
197
1.38
0.82
1.4
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
32
1.88
0.82
1.8
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
73
1.65
0.81
1.7
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
58
1.73
0.79
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
223
0.67
0.79
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
349
0.74
0.78
1.3
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
98
1.54
0.78
1.5
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
122
0.57
0.78
1.6
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
39
491
0.79
0.75
2.1
2.2
nmol/l
12.7
12.1
0.12
28
412
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
90
774
1.18
0.75
4.7
3.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
75
1.61
0.75
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
25
2.00
0.72
1.0
2.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
40
1.75
0.71
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
72
843
0.84
0.71
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
143
0.63
0.70
1.4
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
410
1.23
0.69
2.6
2.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
61
1.64
0.68
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
25
327
0.76
0.66
2.0
2.6
—
16.4
—
0
9
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
22
293
0.74
0.66
1.1
1.4
—
58.1
—
0
18
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
128
1.41
0.65
1.6
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
79
1.52
0.62
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
260
2427
1.10
0.61
5.8
4.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
14
96
1.46
0.61
3.1
1.8
%
86.8
89.2
0.37
14
96
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
50
1.60
0.61
2.4
1.6
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
20
0.00
0.60
0.0
1.3
—
118.3
—
0
13
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
72
1.53
0.59
1.1
1.1
u/ml
304.0
334.2
—
5
47
(3043410) Blood group antigens tested for on Red Blood Cells
0
23
0.00
0.58
0.0
3.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
475
1.19
0.58
1.3
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
54
1.48
0.57
1.0
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
679
6610
1.08
0.56
43.9
23.4
e9/l
228.2
238.3
3.24
655
6336
(3035941) MCH [Entitic mass]
679
6610
1.08
0.56
43.8
23.3
pg
30.3
30.5
1.41
660
6418
(4062490)
6
36
1.67
0.56
1.2
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
36
1.67
0.56
3.5
3.8
—
—
—
0
0
(3024731) MCV [Entitic volume]
679
6611
1.08
0.56
43.9
23.3
fl
92.1
91.8
0.77
660
6420
(3026361) Erythrocytes [#/volume] in Blood
679
6611
1.08
0.56
43.9
23.4
e12/l
4.3
4.3
4.34
648
6302
(40768441) Liver Pathology biopsy report
6
37
1.62
0.55
1.0
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
679
6613
1.08
0.55
44.3
23.6
g/l
127.5
131.6
8.32
659
6424
(3010813) Leukocytes [#/volume] in Blood
679
6613
1.08
0.55
44.0
23.4
e9/l
7.4
7.1
3.65
649
6309
(3021901) Oxygen saturation in Capillary blood
18
134
1.35
0.53
4.0
2.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
160
1471
1.10
0.53
1.9
1.6
mmol/l
1.2
1.3
0.52
148
1184
(3035320) C reactive protein [Mass/volume] in Body fluid
6
40
1.50
0.51
4.0
2.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
18
135
1.34
0.51
3.4
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
76
858
0.88
0.50
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
65
1.39
0.50
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
92
1.42
0.50
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
48
409
1.18
0.49
1.6
1.6
%
2.0
1.6
1.20
38
330
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
76
1.45
0.48
2.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
77
1.43
0.45
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
77
1.43
0.45
2.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
48
554
0.86
0.44
6.4
4.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
51
1.37
0.44
1.0
1.3
—
—
—
0
0
(4010399)
37
436
0.84
0.44
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
78
1.41
0.43
2.4
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
56
1.43
0.42
1.3
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
32
1.56
0.42
2.6
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
139
0.72
0.42
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
131
1.30
0.42
1.4
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
58
1.38
0.41
1.0
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
12
161
0.74
0.41
1.3
3.5
u/ml
87.3
2259.2
0.80
12
154
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
33
1.52
0.41
2.0
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
15
114
1.32
0.40
3.3
1.7
mmol/l
1.6
1.6
0.15
15
114
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
35
1.43
0.39
1.4
3.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
35
1.43
0.39
1.0
1.0
nmol/l
182.8
133.8
—
5
35
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
71
1.41
0.39
1.5
1.7
—
—
—
0
0
(4015189)
0
19
0.00
0.39
0.0
2.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
109
1007
1.09
0.35
1.1
1.2
u/ml
1.0
1.2
0.33
16
230
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
175
1851
0.93
0.35
2.9
3.3
ug/l
0.8
0.8
0.01
113
1317
(3010421) pH of Blood
23
190
1.21
0.34
4.8
4.4
ph
7.4
7.4
0.78
18
156
(3049717) Cytology report of Urine Cyto stain
41
358
1.15
0.34
2.2
3.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
136
1.25
0.33
2.3
2.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
23
274
0.83
0.33
6.4
4.8
—
—
—
0
0
(1002224) Polysomnography panel
14
110
1.28
0.31
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
7
53
1.32
0.31
1.0
1.2
—
195.4
—
0
13
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
315
3258
0.95
0.30
4.6
5.7
ug/l
3.1
5.1
0.71
272
2840
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
15
120
1.25
0.30
1.4
1.3
e6/l
2.3
38.6
—
10
100
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
15
120
1.25
0.30
1.4
1.3
e6/l
2180.7
1198.7
—
10
104
(3008898) HLA-B27 [Presence]
11
84
1.31
0.30
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
194
1.19
0.29
1.3
1.5
ug/g
155.5
262.7
1.87
13
115
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
546
5565
0.96
0.28
30.0
15.5
ml/min/173m2
65.0
70.5
6.87
484
4580
(3019832) Treponema pallidum Ab [Presence] in Serum
16
131
1.22
0.27
2.1
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
72
0.69
0.26
1.4
1.5
pmol/l
106.0
362.1
—
5
72
(3012501) Base excess in Blood by calculation
19
160
1.19
0.25
5.5
4.7
mmol/l
2.9
2.8
0.08
13
108
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
76
817
0.92
0.25
2.6
4.1
ug/l
19.4
35.1
0.37
59
696
(3022145) Colonoscopy Study observation
57
620
0.91
0.24
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
66
711
0.92
0.23
5.9
3.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.0
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
5
39
1.28
0.23
1.0
1.5
—
—
—
0
0
(4211845)
5
40
1.25
0.22
1.4
3.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
79
1.27
0.22
2.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
79
1.27
0.22
2.5
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
79
1.27
0.22
2.9
4.2
—
—
—
0
0
(4281824)
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
171
1641
1.05
0.21
5.2
4.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.6
3.9
nmol/l
324.8
103.5
—
5
42
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
0.4
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.9
—
1.4
—
0
5
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
2.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
101
0.79
0.21
1.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
80
1.25
0.20
2.5
1.4
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
17.3
—
0
14
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
1794.2
—
0
14
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
597
5886
1.03
0.19
5.5
5.0
mmol/l
6.4
6.2
2.25
548
5127
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
58
1.21
0.18
1.7
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
178
1720
1.04
0.17
1.7
1.7
pmol/l
55034009.3
11295384.6
0.37
149
1390
(3008037) Lactate [Moles/volume] in Venous blood
24
215
1.12
0.16
5.2
2.9
mmol/l
2.0
1.6
0.49
24
210
(3017732) Neutrophils [#/volume] in Blood
34
367
0.92
0.14
4.2
3.2
e9/l
5.3
4.0
0.93
26
256
(3006184) Hemoglobin [Mass/volume] in Capillary blood
18
160
1.13
0.14
3.1
2.2
g/l
130.1
128.4
0.11
13
117
(40767503) Oxygen content in Capillary blood by calculation
17
152
1.12
0.12
4.0
2.4
%
16.6
16.3
—
8
72
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
116
0.86
0.12
1.3
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
218
0.92
0.10
1.1
1.2
iu/ml
160.4
114.1
—
6
68
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
46
1.09
0.09
2.8
2.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
95
922
1.03
0.09
15.0
7.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
46
481
0.95
0.08
3.0
3.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
26
244
1.07
0.08
2.0
2.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
81
0.86
0.07
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
100
0.90
0.06
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
102
0.88
0.06
2.9
2.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
109
0.92
0.04
1.3
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
127
0.94
0.02
1.1
1.1
—
10.3
—
0
9
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
103
1.07
0.01
3.2
3.9
%
63.4
59.8
0.32
11
103
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
183
1.04
0.01
2.3
2.4
ug/min
76.2
98.1
0.19
12
112
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
196
0.97
0.00
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
48
475
1.01
0.00
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
50
496
1.01
0.00
1.6
2.1
ug/g
292.4
196.2
0.69
37
392
(3000330) Specific gravity of Urine by Test strip
42
424
0.99
0.00
4.4
4.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
263
2628
1.00
0.00
4.3
4.8
%
22.2
22.0
0.07
116
1413
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
99
1.01
0.00
2.6
3.1
e9/l
5.1
4.4
—
10
99
(4094501)
14
135
1.04
0.00
1.1
1.1
—
—
—
0
0
(4034850)
22
215
1.02
0.00
22.9
9.9
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
1.3
1.2
nmol/l
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
84
0.95
0.00
1.4
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
67
0.89
0.00
1.3
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
7
78
0.90
0.00
2.9
2.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
98
0.92
0.00
1.6
1.6
ug/l
16.5
18.6
—
9
98
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_STR_EMBOLIC_WITH_FLIMMER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_STR_EMBOLIC_WITH_FLIMMER | 2.272 [1.99, 2.59] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.224 |
During the follow-up period (1.1.1998 — 31.12.2019), 1978 out of 3053 females with I9_STR_EMBOLIC_WITH_FLIMMER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_STR_EMBOLIC_WITH_FLIMMER | 1.913 [1.69, 2.17] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.03 |
During the follow-up period (1.1.1998 — 31.12.2019), 1881 out of 3320 males with I9_STR_EMBOLIC_WITH_FLIMMER died.
Mortality risk
Mortality risk for people of age
years, who have I9_STR_EMBOLIC_WITH_FLIMMER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.212% | 0.392% |
| 5 | 1.238% | 2.458% |
| 10 | 3.16% | 6.167% |
| 15 | 6.259% | 11.018% |
| 20 | 10.935% | 18.91% |
Relationships between endpoints
↥Index endpoint: I9_STR_EMBOLIC_WITH_FLIMMER – Embolic stroke with flimmer
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data